Product Information
ACETAZOLAMIDE 125 MG TABLET is a generic product labeled by TruPharma LLC, priced at $0.0957 per EA under NDC 52817020010. Its NADAC has been published 233 times since Jan 12, 2022.
Strength
125 mg/1
Manufacturer
TruPharma LLCNDC
52817020010
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAZOLAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211372On Market Since
4/19/2021
Pharmacological Classes
Price Statistics
The NADAC for ACETAZOLAMIDE 125 MG TABLET has been published 233 times since Jan 12, 2022, and over the history we have for it it has declined 31.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0957 per EA |
|---|---|
| All-time high | $0.2127 (Aug 16, 2023) |
| All-time low | $0.0633 (Nov 20, 2024) |
| 52-week high | $0.1373 |
| 52-week low | $0.0957 |
| Median price | $0.1373 |
| Average price | $0.1393 |
| Largest weekly change | +51.8% (Feb 23, 2022) |
| Weeks tracked | 233 |
| Tracking since | Jan 12, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETAZOLAMIDE 125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAZOLAMIDE 125 MG TABLET, manufactured by TruPharma LLC, is $0.0957 per EA (NDC 52817020010), effective Jun 24, 2026.
How has the price of ACETAZOLAMIDE 125 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACETAZOLAMIDE 125 MG TABLET has declined 31.4%. It has been tracked across 233 weekly CMS publications since Jan 12, 2022.
What are the highest and lowest recorded NADAC prices for ACETAZOLAMIDE 125 MG TABLET?
Since Jan 12, 2022, the NADAC for ACETAZOLAMIDE 125 MG TABLET has ranged from a low of $0.0633 (Nov 20, 2024) to a high of $0.2127 (Aug 16, 2023), with a median of $0.1373 per EA.
Are there cheaper alternatives to ACETAZOLAMIDE 125 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ACETAZOLAMIDE 125 MG TABLET, but none are currently priced below it.
Who manufactures ACETAZOLAMIDE 125 MG TABLET?
ACETAZOLAMIDE 125 MG TABLET (NDC 52817020010) is labeled by TruPharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification